Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Oncology ; 45(5): 350-3, 1988.
Article in English | MEDLINE | ID: mdl-3045726

ABSTRACT

In a randomized trial, 105 postmenopausal women with advanced carcinoma of the breast received tamoxifen or aminoglutethimide or combined tamoxifen and aminoglutethimide. No differences were found in the rate of responses and duration of responses between the treatment groups. Toxicity was significantly greater (p less than 0.01) in patients who received aminoglutethimide.


Subject(s)
Aminoglutethimide/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Tamoxifen/therapeutic use , Adult , Aged , Aminoglutethimide/administration & dosage , Aminoglutethimide/adverse effects , Clinical Trials as Topic , Female , Humans , Menopause , Middle Aged , Random Allocation , Tamoxifen/administration & dosage , Tamoxifen/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...